QuantiPort Partners with Patent Equity Fund, Ideaship, to Provide Physicians with Objective Blood Volume Information

Share Article

QuantiPort today announced it has received a seed investment from Ideaship, a patent leveraged venture capital firm that provides patent development capital to early stage startups. The investment will support QuantiPort’s patent portfolio development related to its disruptive rapid blood volume measurement technology.

“We recognize the technology that QuantiPort is developing has the potential to significantly improve patient care and dramatically reduce mortality rates. We are proud to be partnered with a company whose technology will empower treating physicians to make the best decisions.”

QuantiPort today announced it has received a seed investment from Ideaship, a patent leveraged venture capital firm that provides patent development capital to early stage startups. The investment will support QuantiPort’s patent portfolio development related to its disruptive rapid blood volume measurement technology.

“We recognize the technology that QuantiPort is developing has the potential to significantly improve patient care and dramatically reduce mortality rates. We are proud to be partnered with a company whose technology will empower treating physicians to make the best decisions,” said Michael Lubitz, founder and managing director of Global Technology Transfer (GTT) Group and Ideaship co-founder.

“QuantiPort’s technology is expected to dramatically improve the quality of decisions made by treatment teams in trauma and surgical intensive care, as well as in other applications,” stated Kazutoshi Yasunaga, IP Specialist for Ideaship and Director for Panasonic Intellectual Property Corporation of America.

“Partnering with the Ideaship team has been an incredibly beneficial experience for us,” remarked Theodore Hobbs, founder of QuantiPort. “Every team member has brought their expertise to the table and made our success their mission. Knowing that a team of world class IP experts fully believes in our vision and the viability of our technology is extremely encouraging. We look forward to continuing to learn from the IP experts who comprise Ideaship and to a long-term relationship.”

About QuantiPort
QuantiPort, a medical device startup founded in 2017. Based in Portland, Oregon. QuantiPort is developing a device for the delivery of rapid objective blood volume measurement for critical point of care applications.

For more information, please visit http://www.quantiport.com/.

About Ideaship
Ideaship is a patent leveraged venture capital firm, comprised of world-renowned experts at understanding, articulating, and activating patent value. Ideaship provides patent development capital for early stage ventures. Ideaship combines the wisdom and experience of GTT Group’s patent analysis, valuation, and monetization practices with Panasonic Intellectual Property Corporation of America’s world-leading patent department to achieve enterprise value premiums.

Ideaship is a collaboration between Global Technology Transfer Group and Panasonic Intellectual Property Corporation of America. Ideaship works with founders to maximum enterprise value from their innovations. Ideaship provides the human and monetary capital to capture patent value, while extending operational capital and first mover advantage.

For more information, please visit https://www.ideashipfund.com/.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Robert Bell

Theodore Hobbs
Visit website